pharma · Obesity · Type 2 diabetes
NovoThirteen
News and analysis for NovoThirteen on NovaPharmaNews — regulatory, clinical, and market coverage.
Bagsværd, JP HQ
PMDA registrant Type
Company details
- Status
- Public
- HQ
- Bagsværd, JP
- Programs
- 94
- Drugs
- 67
- Patents
- 0
News & analysis
NovaPharmaNews articles mentioning NovoThirteen — regulatory, clinical, and market coverage.
News and analysis for NovoThirteen on NovaPharmaNews — regulatory, clinical, and market coverage.